Get the latest tech news

Scientists used infrared light to create artificial vision in patients with vision loss

Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said Tuesday.

Ophthalmologist Frank Holz, the trial’s scientific coordinator, called the results a “milestone” in treating severe vision loss caused by age-related macular degeneration. Joseph Rizzo was “impressed” by the study’s results and the eyesight improvements, but the Harvard Medical School ophthalmology professor cautioned against using the layperson’s understanding of visual acuity. “This device is relatively early, but even at this stage, the impact that it’s had for these patients is enormous, and there’s really clear ways to make it better,” said Hodak, who served as Neuralink’s president during the company’s founding.

Get the Android app